BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 580600)

  • 1. Humoral immunity in Graves' disease.
    McKenzie JM; Zakarija M; Sato A
    Clin Endocrinol Metab; 1978 Mar; 7(1):31-45. PubMed ID: 580600
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 3. [Abnormality and deficiency in cellular immunity and internal diseases--Basedow's disease and cellular immunity].
    Shishiba Y
    Nihon Rinsho; 1978; 36(5):960-6. PubMed ID: 353330
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid-stimulating immunoglobulins in Graves' disease.
    Smith BR; Hall R
    Lancet; 1974 Aug; 2(7878):427-31. PubMed ID: 4137321
    [No Abstract]   [Full Text] [Related]  

  • 5. The pathogenesis of Graves' disease and Hashimoto's thyroiditis.
    Volpé R; Farid NR; Von Westarp C; Row VV
    Clin Endocrinol (Oxf); 1974 Jul; 3(3):239-61. PubMed ID: 4601273
    [No Abstract]   [Full Text] [Related]  

  • 6. Ophthalmic Graves' disease. Diagnosis and pathogenesis.
    Hall R; Kirkham K; Doniach D; el-Kabir D
    Lancet; 1970 Feb; 1(7643):375-8. PubMed ID: 4189686
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological studies of the eye changes of thyrotoxicosis.
    Wall JR; Odgers R; Hetzel BS
    Aust N Z J Med; 1973 Apr; 3(2):162-8. PubMed ID: 4515114
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: L.A.T.S. and Graves' disease.
    Volpé R; Farid NR; Von Westarp C; Row VV
    Lancet; 1974 Oct; 2(7884):843. PubMed ID: 4138250
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathogenesis of Graves' disease: an overview.
    Volpé R
    Clin Endocrinol Metab; 1978 Mar; 7(1):3-29. PubMed ID: 348355
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF).
    Lamki L; Row VV; Volpé R
    J Clin Endocrinol Metab; 1973 Feb; 36(2):358-64. PubMed ID: 4739173
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioimmunological studies on the long-acting thyroid stimulator.
    Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
    Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
    [No Abstract]   [Full Text] [Related]  

  • 12. Isoelectric focusing of thyroid-stimulating antibody of Graves' disease.
    Zakarija M; McKenzie JM
    Endocrinology; 1978 Oct; 103(4):1469-75. PubMed ID: 33803
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
    Bonnyns M; Vanhaelst L
    J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid stimulating immunoglobulin (TSI) in Graves' disease.
    Ochi Y; Inui T; Kouki T; Yamashiro K; Hachiya T; Kajita Y
    Endocr J; 1998 Dec; 45(6):701-8. PubMed ID: 10395224
    [No Abstract]   [Full Text] [Related]  

  • 16. [TSH-receptor-bound antithyroid antibody and the etiology of Basedow's disease].
    Shishiba Y
    Nihon Rinsho; 1983; 41(4):801-7. PubMed ID: 6310180
    [No Abstract]   [Full Text] [Related]  

  • 17. [Graves-Basedow type ophthalmopathy and primary hypothyroidism].
    Cathelineau G; Fribourg-Desi M
    Nouv Presse Med; 1974 Sep; 3(32):1995-8. PubMed ID: 4372586
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-acting thyroid stimulator protector assay as a basis for identification of subgroups of Graves' ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith F
    Trans Assoc Am Physicians; 1976; 89():159-70. PubMed ID: 828344
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
    Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
    [No Abstract]   [Full Text] [Related]  

  • 20. The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity.
    Zakarija M
    Horm Res; 1980; 13(1):1-15. PubMed ID: 6777285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.